1. Home
  2. GNLN vs VRAX Comparison

GNLN vs VRAX Comparison

Compare GNLN & VRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Greenlane Holdings Inc.

GNLN

Greenlane Holdings Inc.

HOLD

Current Price

$0.30

Market Cap

1.6M

ML Signal

HOLD

Logo Virax Biolabs Group Limited

VRAX

Virax Biolabs Group Limited

HOLD

Current Price

$0.17

Market Cap

1.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GNLN
VRAX
Founded
2005
2013
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Durable Goods
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6M
1.7M
IPO Year
2019
2021

Fundamental Metrics

Financial Performance
Metric
GNLN
VRAX
Price
$0.30
$0.17
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$1.00
AVG Volume (30 Days)
284.6K
5.6M
Earning Date
05-14-2026
03-10-2026
Dividend Yield
N/A
N/A
EPS Growth
21.57
N/A
EPS
N/A
N/A
Revenue
$13,275,000.00
N/A
Revenue This Year
$1,541.21
$217,274.83
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.01
$0.15
52 Week High
$7.73
$1.34

Technical Indicators

Market Signals
Indicator
GNLN
VRAX
Relative Strength Index (RSI) 26.61 41.28
Support Level N/A N/A
Resistance Level $0.89 $0.25
Average True Range (ATR) 0.12 0.02
MACD -0.02 0.00
Stochastic Oscillator 6.58 10.71

Price Performance

Historical Comparison
GNLN
VRAX

About GNLN Greenlane Holdings Inc.

Greenlane Holdings Inc is a platform for the development and distribution of premium cannabis accessories, vape devices, and lifestyle products. It provides a wide array of consumer ancillary products and industrial ancillary products to thousands of cannabis producers, processors, brands, and retailers (Cannabis Operators). In addition, it serves specialty retailers, smoke shops, head shops, convenience stores, and consumers directly through its proprietary web stores and large online marketplaces such as Amazon. Its geographical segment includes the United States, Canada, and Europe. It derives a majority of revenue from the United States.

About VRAX Virax Biolabs Group Limited

Virax Biolabs Group Ltd is an inventive biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases. Through its ViraxImmune platform and ImmuneSelect portfolio of research-use-only (RUO) products and services, the Company is building an immune-profiling offering that spans RUO assays, preclinical immunology services and, longer term, T cell-based diagnostics aimed at post-acute infection syndromes (PAIS) such as Long COVID and other chronic conditions linked to immune dysregulation.

Share on Social Networks: